Boardroom Alpha
Start trial
10-K primary document
MRVI · Annual Report (Form 10-K) · Filed February 26, 2026

Maravai Lifesciences Holdings Inc — 10-K exhibit

exhibit1042-mrvixamendment.htm
Maravai Lifesciences Holdings Inc on Boardroom Alpha
Document
Exhibit 10.42
AMENDMENT NO. 1 TO
EMPLOYMENT AGREEMENT
THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (this “Amendment”) is dated as of February 19, 2026 and to be effective as of December 31, 2025, by and among Maravai LifeSciences Holdings, Inc., a Delaware corporation (“Parent”), Maravai Intermediate Holdings, LLC, a Delaware limited liability company (“Employer”), and Bernd Brust (“Executive”).
WHEREAS, Parent, Employer and Executive are parties to that certain Employment Agreement dated as of June 8, 2025 (the “Employment Agreement”); and
WHEREAS, the parties desire to amend the Employment Agreement to permit Executive to continue to reside in Dallas, Texas rather than relocate, as set forth in this Amendment.
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Amendment hereby agree as follows:
1.Definitions. Capitalized terms not otherwise defined in this Amendment shall have the meaning given to them in the Employment Agreement.
2.Amendment and Restatement of Section 1(a)(iii). Section 1(a)(iii) of the Employment Agreement is hereby amended and restated as follows:
(i)Executive’s principal place of work shall be his residence in Dallas, Texas; provided, that Executive shall travel as reasonably necessary to fulfill the duties of his employment. Notwithstanding the foregoing, in the event the Board later relocates Executive’s principal place of work to San Diego, California, such relocation shall not constitute grounds for Executive to terminate his employment for Good Reason.
3.Amendment and Restatement of Section 1(d). Section 1(d) of the Employment Agreement is hereby amended and restated as follows:
(a)Private Air Travel. For so long as Parent maintains access to private aircraft, Parent shall make available to Executive private aircraft to use in accordance with its Use of Corporate Aircraft Policy.
4.Agreement in Effect. The Employment Agreement is amended in order to reflect the agreements set forth in this Amendment. Except as modified by this Amendment, all other terms and conditions of the Employment Agreement shall be unchanged and shall remain in full force and effect. In the event of any conflict between the terms of this Amendment and the Employment Agreement, the terms of this Amendment shall control.
* * * * *



IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.
MARAVAI LIFESCIENCES HOLDINGS, INC.
By: /s/ Kurt A. Oreshack    
Name: Kurt. A. Oreshack
Its: General Counsel
MARAVAI INTERMEDIATE HOLDINGS, LLC
By: /s/ Kurt A. Oreshack    
Name: Kurt. A. Oreshack
Its: General Counsel
EXECUTIVE
/s/ Bernd Brust    
Bernd Brust


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer